WO2025075625 - COMPOSITION AND METHOD FOR TREATING MENSTRUATION RELATED SYMPTOMS
National phase entry is expected:
Publication Number
WO/2025/075625
Publication Date
10.04.2025
International Application No.
PCT/US2023/034602
International Filing Date
06.10.2023
Title **
[English]
COMPOSITION AND METHOD FOR TREATING MENSTRUATION RELATED SYMPTOMS
[French]
COMPOSITION ET PROCÉDÉ DE TRAITEMENT DE SYMPTÔMES LIÉS À LA MENSTRUATION
Applicants **
HARRISON, Margo
Inventors
HARRISON, Margo
Priority Data
18/376,910
05.10.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2258 | |
| EPO | Filing, Examination, Granting | 10405 | |
| Japan | Filing, Examination, Granting | 2324 | |
| South Korea | Filing, Examination, Granting | 2356 | |
| USA | Filing, Examination, Granting | 4310 |
Total:
21,653
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention discloses a composition and method for treating menstruation related symptoms. The composition comprises an effective amount of a nonsteroidal anti-inflammatory drug (NSAID) comprising at least one of naproxen and ketoprofen. The composition is administrated before an onset of menstruation or during menstruation. The composition is provided in a pharmaceutical package. The package comprises a label indicating a quantity of the formulation to be consumed for a specific time and day in coordination with a menstrual period.[French]
La présente invention divulgue une composition et un procédé de traitement de symptômes liés à la menstruation. La composition comprend une quantité efficace d'un médicament anti-inflammatoire non stéroïdien (AINS) comprenant au moins un entre naproxène et/ou kétoprofène. La composition est administrée avant le début de la menstruation ou pendant la menstruation. La composition est fournie dans un emballage pharmaceutique. L'emballage comprend une étiquette indiquant une quantité de la formulation à consommer pendant un temps et un jour spécifiques en coordination avec une période menstruelle.